Team portrait

Molecular Imaging Diagnostics

ABSCINT is a clinical stage molecular imaging company that develops in-vivo diagnostics based on single domain antibodies.
ABSCINT
focuses on the development of radiolabelled single domain antibodies for whole body molecular imaging applications. Molecular imaging is used for the diagnosis of disease, for molecular characterisation of a disease, for monitoring treatment response and for detection of disease recurrence. It is based on specific molecular markers that can be visualised over the entire body by a short scan.
The company has two clinical stage products: one in oncology and one in cardiovascular disease.

Meet our team

  • Karine Clauwaert

    Karine Clauwaert

    CEO
    BD specialist

  • Tony Lahoutte

    Tony Lahoutte

    Medical Director

  • Martine Vandermarliere

    Martine Vandermarliere

    CSO
    CMC protein

  • Philippe Van Wolleghem

    Philippe Van Wolleghem

    Chief Quality
    Regulatory officer

  • Henri Baudhuin

    Henri Baudhuin

    Scientist
    Preclinical